[Hypo beta-lipoproteinemia with selective deletion of apo B-48]. 1998

Y Tohdoh, and H Mabuchi
Second Department of Internal Medicine, School of Medicine, Kanazawa University.

UI MeSH Term Description Entries
D006995 Hypobetalipoproteinemias Conditions with abnormally low levels of BETA-LIPOPROTEINS (low density lipoproteins or LDL) in the blood. It is defined as LDL values equal to or less than the 5th percentile for the population. They include the autosomal dominant form involving mutation of the APOLIPOPROTEINS B gene, and the autosomal recessive form involving mutation of the microsomal triglyceride transfer protein. All are characterized by low LDL and dietary fat malabsorption. Familial Hypobetalipoproteinemia,Hypo beta Lipoproteinemia,Hypobetalipoproteinemia,Hypo beta Lipoproteinemias
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D014801 Vitamin A Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products. Retinol,11-cis-Retinol,3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer,All-Trans-Retinol,Aquasol A,Vitamin A1,All Trans Retinol
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.
D053283 Apolipoprotein B-48 A 241-kDa protein synthesized only in the INTESTINES. It serves as a structural protein of CHYLOMICRONS. Its exclusive association with chylomicron particles provides an indicator of intestinally derived lipoproteins in circulation. Apo B-48 is a shortened form of apo B-100 and lacks the LDL-receptor region. Apo B, Chylomicron,Apo B-48,ApoB-48,ApoB48,Apolipoprotein B, Chylomicron,Apolipoprotein B48,Apoprotein B-48,Chylomicron Apo B,Chylomicron Apolipoprotein B,Apo B 48,ApoB 48,Apolipoprotein B 48,Apoprotein B 48
D018752 Diet, Fat-Restricted A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIAS. (From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed) Diet, Fat-Free,Diet, Low-Fat,Fat-Restricted Diet,Diet, Fat Free,Diet, Fat Restricted,Diet, Low Fat,Diets, Fat-Free,Diets, Fat-Restricted,Diets, Low-Fat,Fat Restricted Diet,Fat-Free Diet,Fat-Free Diets,Fat-Restricted Diets,Low-Fat Diet,Low-Fat Diets

Related Publications

Y Tohdoh, and H Mabuchi
December 1987, International journal of dermatology,
Y Tohdoh, and H Mabuchi
November 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Y Tohdoh, and H Mabuchi
July 1981, Clinica chimica acta; international journal of clinical chemistry,
Y Tohdoh, and H Mabuchi
May 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Y Tohdoh, and H Mabuchi
November 1973, Acta medica Scandinavica,
Y Tohdoh, and H Mabuchi
January 1970, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
Y Tohdoh, and H Mabuchi
December 1977, American journal of diseases of children (1960),
Y Tohdoh, and H Mabuchi
February 1988, Atherosclerosis,
Copied contents to your clipboard!